“Impact on diabetes control and patient-reported outcomes of a newer implantable continuous glucose monitoring system (Eversense® CGM System): a single-centre retro- and prospective observational study” (2024) Swiss Medical Weekly, 154(3), p. 3366. doi:10.57187/s.3366.